Benzinga | Jun 24, 2021 07:24AM EDT

Jefferies Initiates Coverage On Inovio Pharmaceuticals with Hold Rating, Announces Price Target of $9

Jefferies analyst Kelechi Chikere initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Hold rating and announces Price Target of $9.